Read More

Genetron Health Announced Late Monday, A Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China

Genetron Holdings Limited (NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it has signed a collaboration agreement with AstraZeneca R&D China (Nasdaq:

AZN

Read More

Genetron Health Announced Release of Two Cancer Research Study Results at the Association for Molecular Pathology 2021 Annual Meeting

Genetron Holdings Limited (NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of two research results from its Seq-MRD® and FusionScan Plus product stu

GTH